sr 48692 has been researched along with bradykinin in 1 studies
| Studies (sr 48692) | Trials (sr 48692) | Recent Studies (post-2010) (sr 48692) | Studies (bradykinin) | Trials (bradykinin) | Recent Studies (post-2010) (bradykinin) |
|---|---|---|---|---|---|
| 203 | 3 | 36 | 14,195 | 355 | 1,520 |
| Protein | Taxonomy | sr 48692 (IC50) | bradykinin (IC50) |
|---|---|---|---|
| B2 bradykinin receptor | Homo sapiens (human) | 0.0018 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carraway, RE; Cochrane, DE; Feldberg, RS; Miller, LA | 1 |
1 other study(ies) available for sr 48692 and bradykinin
| Article | Year |
|---|---|
Blockade of mast cell histamine secretion in response to neurotensin by SR 48692, a nonpeptide antagonist of the neurotensin brain receptor.
Topics: Animals; Bradykinin; Dose-Response Relationship, Drug; Histamine; Histamine Release; Male; Mast Cells; Neurotensin; Pyrazoles; Quinolines; Rats; Rats, Sprague-Dawley; Substance P; Time Factors | 1995 |